2 Beaten-Down Stocks to Buy and Hold
Key PointsApple and Eli Lilly have impressive long-term track records of returns.
Key PointsApple and Eli Lilly have impressive long-term track records of returns.
Opendoor (OPEN) is suddenly the comeback story no one saw coming. Once left for dead as a failed SPAC trading at just $0.50, Opendoor stock has skyrocketed more than 20X
For FY23, the Glucon-D maker’s standalone net profit stood at ?66 crore, a 400 percent jump from the previous fiscal Zydus wellness owns brands like Glucon D, Sugarfree and Nutralite. ‘); $(‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] < 0){ // $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); // $(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); //} if(resData[stkKey][‘percentchange’]
For FY23, the Glucon-D maker’s standalone net profit stood at ?66 crore, a 400 percent jump from the previous fiscal Zydus wellness owns brands like Glucon D, Sugarfree and Nutralite. ‘); $(‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] < 0){ // $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); // $(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); //} if(resData[stkKey][‘percentchange’]
USFDA inspected Zydus Lifesciences’ Onco injectable manufacturing plant in Ahmedabad from March 18 to 27 Zydus Lifesciences ‘); $(‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] < 0){ // $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); // $(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); //} if(resData[stkKey][‘percentchange’] >= 0){ $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $(‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] < 0){ $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); //$(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); $(‘#gainlosstxt_’+articleId).find(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); }
USFDA inspected Zydus Lifesciences’ Onco injectable manufacturing plant in Ahmedabad from March 18 to 27 Zydus Lifesciences ‘); $(‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] < 0){ // $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); // $(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); //} if(resData[stkKey][‘percentchange’] >= 0){ $(‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$(‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $(‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] < 0){ $(‘#greentxt_’+articleId).removeClass(“greentxt”).addClass(“redtxt”); //$(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); $(‘#gainlosstxt_’+articleId).find(‘.arw_green’).removeClass(“arw_green”).addClass(“arw_red”); }